The clinical standard for blood pressure measurement remains the cuff-based sphygmomanometer, whether the mercury column of the classic doctor’s office device or the oscillometric machines found in pharmacies and homes. These instruments work by occluding an artery and inferring pressure from the behavior of blood flow beneath the cuff. While accurate at a single moment, cuffs are bulky, uncomfortable, and fundamentally unsuited to continuous monitoring. They cannot be worn overnight, they disturb the very physiology they measure by compressing vessels, and readings taken in clinical settings are notoriously vulnerable to “white coat” effects, in which the stress of measurement itself elevates the numbers. Dynamic, around-the-clock blood pressure data would allow physicians to capture the full circadian profile of a patient’s cardiovascular system, revealing nocturnal hypertension, morning surges, and other patterns that spot checks miss entirely.

The new device, called a microcavity-assisted graphene pressure sensor (MAGPS), was developed by a team led by researchers at Sun Yat-sen University’s School of Biomedical Engineering in Shenzhen, with collaborators at Tsinghua University, the Shenzhen Institutes of Advanced Technology, and the Seventh Affiliated Hospital of Sun Yat-sen University. At its heart is a familiar challenge in flexible pressure sensor design: sensors that are highly sensitive typically saturate at low pressures, while sensors that can withstand high pressures sacrifice sensitivity. Blood pressure monitoring at the radial artery demands both, because the sensor must detect subtle pulse waveforms superimposed on a substantial static contact pressure from the wrist strap that holds it in place.

The team’s solution lies in a microcavity structure built into the sensor. Rather than allowing applied pressure to compress the graphene sensing element directly and fully, the microcavity traps a volume of gas that buffers the load, distributing and moderating the force that reaches the active layer. This gas pressure buffering extends the sensor’s usable range dramatically. In the reported measurements, the MAGPS achieves an extraordinarily wide linear response spanning 0 to 1050 kilopascals — a range that comfortably covers everything from gentle touch to the combined static and pulsatile pressures encountered at the radial artery — while maintaining a high sensitivity of 15.4 per kilopascal. The graphene itself, a two-dimensional carbon material prized for its exceptional mechanical flexibility and strong piezoresistive response, converts minute deformations of the sensor membrane into measurable electrical signals as blood pulses through the vessel beneath.

With the hardware in hand, the researchers set about building the data infrastructure needed to translate raw pulse waveforms into clinically interpretable blood pressure values. They assembled a database comprising 228 sixty-second blood pressure data fragments and 11,804 individual pulse waves, collected from fourteen subjects: nine healthy individuals and five with hypertension. Each recording captured the radial artery pulse through the MAGPS while reference measurements established ground-truth systolic and diastolic pressures. This dataset formed the training and evaluation foundation for the machine learning component of the system, which the researchers describe as a two-stage convolutional neural network algorithm.

The two-stage design reflects the clinical logic of hypertension assessment. In the first stage, the algorithm examines the morphology of the pulse wave — the distinctive shape of pressure oscillations as they propagate along the arterial wall — and classifies whether the subject shows signs of hypertension. This triage step matters because hypertensive patients exhibit altered arterial properties, including stiffer vessel walls and changed wave reflections, that imprint recognizable signatures on the pulse waveform. Once the classification is made, the second stage performs the finer task of quantifying actual pressure values. Working on the same pulse wave data, this network estimates systolic and diastolic blood pressure with accuracies of 93.5 percent and 97.8 percent, respectively, within an error tolerance of 10 millimeters of mercury — the threshold widely used in international validation standards for blood pressure measuring devices.

The significance of this performance is best understood against the landscape of existing cuffless approaches. Many current methods rely on indirect proxies for pressure, most commonly pulse wave velocity, the speed at which the arterial pulse travels between two measurement points. This relationship, rooted in physics dating back to the nineteenth century, requires calibration and assumes vascular properties that vary between individuals and change over time. Other strategies use bioimpedance sensors, ultrasonic devices, or photoplethysmography, each with trade-offs in comfort, complexity, and reliability. The MAGPS approach is more direct: by pressing gently on a single vessel and reading its pulsation with high fidelity, it accesses local blood pressure information at the source, without needing anatomical assumptions about the wave’s travel path or multi-site instrumentation.

The choice of the radial artery is also deliberate. It is the vessel most commonly palpated in clinical practice, it is superficially accessible at the wrist, and it carries rich diagnostic information — practitioners of traditional pulse diagnosis and modern cardiology alike have long read the radial pulse for clues about cardiovascular state. A sensor that wraps around the wrist and continuously listens to this vessel could integrate naturally into wristbands and smartwatches, the form factors that hundreds of millions of people already wear daily. Unlike cuff-based ambulatory monitors that inflate periodically and disturb sleep, a pulse-reading patch could gather data silently and continuously, potentially transforming the detection and management of conditions such as nocturnal hypertension and resistant hypertension.

The researchers emphasize that the microcavity innovation is what makes the approach practical. Without the gas-buffering structure, the large static pressure from a wrist strap would push most sensitive sensors past their linear range, compressing the dynamic pulse signal into unreadable saturation. By widening the linear window to 1050 kilopascals while retaining high sensitivity, the MAGPS preserves the fidelity of the pulse waveform even under realistic wearing conditions. This combination of range and sensitivity in a single flexible device has been a long-sought goal in the field of wearable pressure sensing, and the microcavity design offers a generalizable architectural strategy that could benefit sensors beyond blood pressure monitoring, including applications in tactile sensing and human-machine interfaces.

As with any early-stage biomedical technology, the path from a fourteen-subject laboratory study to widespread clinical adoption involves substantial further validation. Larger and more diverse patient populations, longitudinal studies of sensor drift and calibration stability, comparison against gold-standard intra-arterial measurements in appropriate settings, and integration into regulatory frameworks for medical devices all lie ahead. The researchers themselves frame the work as a demonstration of a new detection method based on a single vessel, one that greatly improves the efficiency of blood pressure measurement rather than a finished clinical product. Still, the convergence of flexible graphene electronics, structural engineering, and deep learning shown here points toward a future in which blood pressure is not something measured occasionally at the doctor’s office, but a continuous stream of physiological data captured effortlessly throughout the day — turning the humble wrist into a window on the cardiovascular system.

The system, called MOSAIC, is designed to address a longstanding problem in critical care. Patients in intensive care units can experience sudden and dangerous changes in blood pressure, sometimes within minutes. A pressure that rises too high may increase the risk of stroke, heart attack, and kidney injury, while a pressure that falls too low can reduce blood flow to the brain and other vital organs. Detecting these changes early is often essential, but the current method for doing so continuously requires placing a catheter directly inside an artery.

Arterial lines provide highly detailed, beat-by-beat measurements and are widely regarded as the clinical reference standard for continuous blood-pressure monitoring. Yet inserting an arterial catheter is an invasive procedure. The catheter can cause bleeding, clot formation, infection, or damage to the artery, and it restricts a patient’s movement. The line must also be carefully maintained and monitored by clinical staff. These drawbacks mean that continuous arterial monitoring is generally reserved for patients whose condition is serious enough to justify the risks.

Conventional arm cuffs avoid those risks but introduce a different limitation: they measure blood pressure only intermittently. A cuff inflates periodically, records a pressure reading, and then remains inactive until the next measurement. That approach can miss rapid fluctuations between readings. It also tends to interrupt sleep, limit movement, and provide clinicians with isolated numbers rather than a continuous picture of how pressure changes from one heartbeat to the next.

MOSAIC uses two small sensors to capture the physiological signals needed to estimate blood pressure without entering the bloodstream. One sensor is positioned on the chest to record the heart’s electrical activity, similar to an electrocardiogram. The second is placed on a finger, where it detects changes in blood volume as pulses of blood move through the circulation. This optical or pulse-related signal provides information about the timing and shape of blood flow. Together, the signals describe how electrical activation of the heart relates to the arrival and movement of blood through the body.

The system then sends those measurements to a deep-learning model. Rather than producing only a single systolic and diastolic value, the algorithm reconstructs a blood-pressure waveform, a continuously changing curve that represents pressure over time. The waveform contains information about each heartbeat, including the rise and fall of arterial pressure and the timing of pulse transmission. In principle, this gives clinicians a richer view of cardiovascular changes than a sequence of occasional cuff readings.

The researchers trained and evaluated the system by comparing its reconstructed waveforms with measurements from arterial catheters already being used in patients at Johns Hopkins Hospital. In the initial group of 28 intensive care patients, the signals generated by MOSAIC closely matched the waveforms recorded by the invasive lines. The result does not yet establish that the wearable system can replace arterial catheters in routine care, but it indicates that signals collected from the skin may contain enough information for artificial intelligence to estimate arterial pressure with clinically meaningful detail.

The technical challenge is substantial because blood pressure is influenced by many factors, including heart rhythm, vascular resistance, blood volume, body position, temperature, medications, and movement. The relationship between a pulse detected at the finger and pressure inside a major artery can change from person to person and over time. A deep-learning model can identify complex patterns in the electrical and pulse signals that are difficult to capture with a simple equation, but its performance must remain reliable across different patients, illnesses, skin conditions, sensor placements, and levels of physical activity.

“We reconstruct waveform data in a way that’s meaningful, accurate, reliable and, most importantly, non-invasive,” said senior author Robert Stevens, chief of the Division of Informatics, Integration, and Innovation at Johns Hopkins Medicine. Lead author Carl Harris, a biomedical engineering doctoral student, said the team was seeking an alternative to arterial lines because of their risks of bleeding, clotting, and infection.

The investigators are now testing MOSAIC in a larger cohort of intensive care patients. That next phase will be important because a study of 28 people cannot fully capture the range of physiological conditions encountered in critical care. Larger validation studies will need to determine how accurately the system performs during severe infection, shock, irregular heart rhythms, rapid changes in medication, low blood flow to the extremities, and patient movement. Researchers will also need to establish how the algorithm behaves when sensor signals are noisy or temporarily interrupted.

If the technology continues to perform well, its uses could extend beyond intensive care. A non-invasive continuous monitor could allow clinicians to follow patients in regular hospital wards without transferring them to an intensive care unit simply because they need closer blood-pressure observation. It might also enable earlier recognition of deterioration in patients who are recovering from surgery or serious illness, while allowing them greater freedom to move than an arterial catheter permits.

The researchers also envision a future in which people with hypertension wear similar sensors for extended periods outside the hospital. High blood pressure is among the world’s most common health conditions and a major contributor to cardiovascular disease, stroke, and kidney damage. Current home monitoring usually relies on occasional cuff measurements, which can be useful but may not reveal how pressure changes during work, exercise, sleep, stress, or ordinary daily activity. Continuous data could show patterns that are invisible in isolated readings and might help physicians adjust treatment more precisely.

That possibility resembles the transformation brought by wearable glucose monitors, which allow people with diabetes to observe changes in blood sugar throughout the day rather than relying only on occasional tests. Continuous blood-pressure monitoring could eventually provide a similar window into cardiovascular health, although the comparison should be treated cautiously. Blood-pressure measurement is technically complex, and a device intended for medical decisions must demonstrate accuracy and reliability across a wide population before it can be used broadly.

The system could also help researchers study blood pressure in healthy people. Most detailed blood-pressure data currently come from patients who are already ill or undergoing medical procedures. Less is known about how pressure changes in people as they commute, work, exercise, sleep, and interact with their environment. Long-term wearable monitoring could reveal previously overlooked patterns and improve understanding of how everyday behavior and stress affect cardiovascular risk.

For now, MOSAIC remains an investigational technology rather than a replacement for the arterial line. Its encouraging first test shows that wearable sensors and artificial intelligence can reproduce invasive blood-pressure waveforms with surprising fidelity, but larger studies and rigorous clinical validation are still required. If those studies confirm the initial results, the technology could shift continuous blood-pressure monitoring away from the artery and toward the skin, bringing real-time cardiovascular information to more patients in hospitals and, eventually, at home.

Subject of Research: Non-invasive continuous blood-pressure monitoring using wearable sensors and artificial intelligence.

Article Title: Wearable Sensors and Artificial Intelligence Bring Continuous Blood Pressure Monitoring Out of the ICU

Web References: Johns Hopkins University research announcement; https://www.sciencedirect.com/science/article/abs/pii/S0010482526004257

References: Computers in Biology and Medicine, DOI: 10.1016/j.compbiomed.2026.111861

Keywords

Wearable sensors, artificial intelligence, deep learning, blood pressure, continuous monitoring, arterial line, intensive care, hypertension, biomedical engineering, cardiovascular health

Hypertension, recognized as a leading chronic disease, poses considerable risks associated with severe cardiovascular events such as heart attacks, strokes, and heart failure. Traditional methods of measuring blood pressure rely heavily on cuff-based techniques, which are both intermittent and invasive. These conventional approaches often fail to capture the dynamic fluctuations in blood pressure that can occur throughout an individual’s day-to-day activities. The inability to monitor these changes in real-time presents significant challenges in managing a patient’s cardiovascular health, creating an urgent need for innovative solutions.

Enter the wearable blood pressure sensor, a technology designed to provide a non-invasive alternative for continuous blood pressure tracking. These sensors generate the potential to realize personalized health management through real-time data collection, thus allowing for proactive interventions. However, the current existing technologies are hindered by challenges related to accuracy and reliability, making them less than ideal for medical applications. This has necessitated advancements not only in sensor design but also in AI-driven signal processing algorithms that can interpret the complex data these sensors yield.

The research team at KAIST has taken steps beyond previous explorations and experiments, such as those reported in their earlier work published in Advanced Materials, where they successfully validated the clinical applicability of flexible piezoelectric blood pressure sensors. In their latest work, the KAIST researchers undertook a comprehensive analysis of the emerging territory of cuffless wearable sensors. They meticulously examined the main technical and clinical challenges that hinder the widespread acceptance and application of these devices.

One crucial aspect of their research involved investigating the clinical aspects necessary for successful implementation. Their findings emphasize the importance of real-time data transmission capabilities, as a lack of seamless communication could significantly jeopardize the effectiveness of these wearable sensors. Furthermore, they noted that signal quality degradation, particularly during movement or physical activity, presents a formidable hurdle that must be surmounted for these devices to deliver reliable readings consistently.

The researchers also dedicated significant attention to improving the accuracy of AI algorithms used in blood pressure estimation. The interplay between the raw data captured by the sensors and the algorithm’s ability to correctly interpret that data is critical in ensuring that the readings provided by these devices are trustworthy and actionable. As Professor Keon Jae Lee articulated, their research systematically showcases the feasibility of developing medical-grade wearable blood pressure sensors and proposes new theoretical strategies to surmount the technical barriers currently faced.

Through continued developments in sensor technology and algorithm sophistication, there is growing optimism regarding the future commercialization of these wearable devices. Such advancements not only aim to cultivate consumer trust in these products but also endeavor to significantly improve the quality of life for individuals managing hypertension and related cardiovascular conditions. The researchers foresee a future where these sensors will not merely be experimental devices but will find their rightful place in everyday medical applications.

Moreover, their comprehensive review titled “Wearable blood pressure sensors for cardiovascular monitoring and machine learning algorithms for blood pressure estimation,” published on February 18, 2025, in Nature Reviews Cardiology, exemplifies the depth and breadth of current research focused on this field. The high impact factor of the journal underscores the importance and relevance of their findings to the scientific community, further illustrating the urgent need for continued innovation in wearable health technology.

The broader implications of these findings could extend beyond isolated cases of hypertension. With the escalating prevalence of cardiovascular diseases worldwide, the demand for more innovative, reliable, and user-friendly monitoring solutions will only continue to grow. The KAIST team’s work represents a significant leap toward addressing these needs, potentially enhancing the ability of healthcare providers to deliver timely interventions based on accurate real-time data.

Healthcare systems globally are gradually shifting from reactive to proactive models of patient care, and innovations such as these wearable sensors are pivotal to this progressive approach. Embracing the use of AI and sophisticated technologies in personal health management could ultimately lead to improved patient outcomes and more efficient healthcare delivery systems.

In conclusion, the drive for more sophisticated wearable blood pressure sensors heralds a new era in cardiovascular health management. As ongoing research continues to refine these technologies, it is expected that they will soon become integral tools not only in clinical settings but also in everyday life, empowering individuals to take charge of their cardiovascular health with unprecedented accuracy and convenience.

Subject of Research:
Article Title: Wearable blood pressure sensors for cardiovascular monitoring and machine learning algorithms for blood pressure estimation.
News Publication Date: 18-Feb-2025
Web References: doi.org/10.1038/s41569-025-01127-0
References: Min S. et al., (2025).
Image Credits: KAIST Human Augmentation Nano Device Laboratory

Keywords: Cardiovascular health, wearable technology, AI algorithms, blood pressure monitoring, hypertension, medical innovations